Home › Funds › NUANCE INVESTMENTS, LLC › TECH
NUANCE INVESTMENTS, LLC position in TECH
BIO-TECHNE CORP · Health Care
NUANCE INVESTMENTS, LLC reported holding 428,379 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$31.0M, representing 5.70% of its reported portfolio and ranking #4 among its reported holdings. NUANCE INVESTMENTS, LLC has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NUANCE INVESTMENTS, LLC's TECH position evolved
NUANCE INVESTMENTS, LLC first disclosed a stake in TECH in Q2 2026 at 105,796 shares (US$7.5M). The position peaked in Q3 2026 at 428,379 shares, worth US$31.0M. Across 2 filings, NUANCE INVESTMENTS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 428,379 shares valued at US$31.0M — an increase of 322,583 shares quarter over quarter.. Notable position changes include a 305% increase in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 105.80K | $7.47M | New |
| Q3 2026 | 428.38K | $31.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M sh · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- Qube Research & Technologies Ltd 2.38M sh · $172.44M · Q3 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on NUANCE INVESTMENTS, LLC
FAQ
How long has NUANCE INVESTMENTS, LLC held TECH?
NUANCE INVESTMENTS, LLC has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is NUANCE INVESTMENTS, LLC's current position in TECH?
As of Q3 2026, NUANCE INVESTMENTS, LLC holds 428.38K shares of TECH (BIO-TECHNE CORP), valued at $31.04M, representing 5.70% of its reported portfolio and ranking #4.
Has NUANCE INVESTMENTS, LLC been buying or selling TECH?
In the latest 13F filing (Q3 2026), NUANCE INVESTMENTS, LLC increased its position in TECH. The position peaked in Q3 2026 at 428.38K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.